BioSpace News Archive

This acquisition expands Agilent’s cell analysis portfolio with the addition of easy-to-use assay kits that are compatible with industry standard plate-readers.

Medidata today announced that the Medical Research Collaborating Center (MRCC), one of the leading research centers of biomedical science in South Korea, has selected Medidata Rave® to accelerate the overall regulatory data submission process during clinical trials.

Renovacare, (OTCQB: RCAR), developer of the SkinGun™ and CellMist™ System for isolating and spraying a patient’s own stem cells onto burns and wounds for rapid self-healing, is pleased to provide its outlook for 2018, which includes a shareholder update on the Company’s plans to advance its products towards market.

Cantor Fitzgerald & Co. and Mizuho Securities USA LLC are acting as joint book-running managers for the offering.

Teleflex announced that more than 200,000 ClosureFast® Catheters have been successfully reprocessed by the company’s partner, Northeast Scientific, Inc. (NES), since NES received FDA clearance for reprocessing the popular vein ablation catheter in 2011.

The slide box introduces a durable solution for every day users in research labs with features like a removable inventory card that is replaceable when full and a centrally positioned location grid for easy viewing and retrieving of slides.

Dr. Li has more than 20 years of experience in biologics.

Appili Therapeutics announced today it has signed a licence agreement with the National Research Council of Canada (NRC) to develop ATI-1701, a vaccine to protect against Francisella tularensis, a potential bioterrorism agent that causes tularemia.

The results provide evidence that GTP-004 enables the safe and well-tolerated administration of doses of pyridostigmine.

For the fiscal first quarter 2018, the company expects worldwide revenue of approximately $670M.